- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05379933
Caregiver Protocol for Remotely Improving, Monitoring, and Extending Quality of Life (C-PRIME)
January 19, 2023 updated by: H. Lee Moffitt Cancer Center and Research Institute
C-PRIME: Caregiver Protocol for Remotely Improving, Monitoring, and Extending Quality of Life
The purpose of this study is to test an intervention to improve health promoting behaviors in family caregivers of patients receiving cancer therapy
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
33
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Tampa, Florida, United States, 33612
- Moffitt Cancer Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Eligible family caregivers will be:
- An unpaid family member or friend who provides assistance and support with healthcare of a non-institutionalized patient receiving some form of treatment for stage III or IV colorectal cancer at Moffitt Cancer Center
- Age 18+ years
- English or Spanish speaking
- Able to complete questionnaires and engage in short discussions with coaches
- Able to identify a primary care medical provider
- Willing/able to use a mobile device provided by the study team or their own their device.
Exclusion Criteria:
- Participants who do not meet the study inclusion criteria
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: C-PRIME
Participants will wear an activity tracker for 8 weeks.
During the 8 weeks of the study, participants will complete weekly survey questions about health and well-being and engage in weekly, 15-20 minute telephone/videoconference coaching sessions with a health coach.
|
Participants will be asked to wear an activity tracker, complete brief surveys, and participate in weekly health coaching sessions remotely for 8 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of Participants Who Agree to Participate (Acceptability)
Time Frame: 12 Months
|
The study will be deemed acceptable if at least 50% of eligible family caregivers agree to participate
|
12 Months
|
Percentage of Participants Who Provide Data (Feasibility)
Time Frame: 12 Months
|
The study will be deemed feasible if at least 75% of family caregivers who participate provide data for at least 50% of study days
|
12 Months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Self Care Behaviors - Primary Efficacy
Time Frame: 8 Weeks
|
Participant's self care behaviors will be measured using the Health-Promoting Lifestyle Profile-II.
This is a 52-item questionnaire that assesses use of behaviors likely to promote a healthy lifestyle and indicate greater selfcare.
Responses are categorized into an overall health-promoting lifestyle score as well as subscales assessing health responsibility, physical activity, nutrition, spiritual growth, interpersonal relations, and stress management.
|
8 Weeks
|
Quality of Life -Secondary Efficacy
Time Frame: 8 Weeks
|
Participants' quality of life will be assessed using the EORT QLQ-C30, a 30-item measure that assesses quality of life in various domains of functioning and symptoms.
|
8 Weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Brian Gonzalez, PhD, Moffitt Cancer Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 11, 2022
Primary Completion (Actual)
November 15, 2022
Study Completion (Actual)
November 15, 2022
Study Registration Dates
First Submitted
May 13, 2022
First Submitted That Met QC Criteria
May 13, 2022
First Posted (Actual)
May 18, 2022
Study Record Updates
Last Update Posted (Actual)
January 20, 2023
Last Update Submitted That Met QC Criteria
January 19, 2023
Last Verified
January 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MCC-21751
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Quality of Life
-
Assiut UniversityUnknownImproving Quality of LifeEgypt
-
Children's National Research InstituteCompletedProfessional Quality of LifeUnited States
-
Istituto Ortopedico RizzoliUniversity of BolognaActive, not recruitingImprove Quality of LifeItaly
-
B. Braun Medical SAUnknownQuality of Life of Colostomized Patient
-
Mattu UniversityCompletedBreif Description: Patients' Quality of Life ofEthiopia
-
University of South CarolinaNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingHealth Related Quality of LifeUnited States
-
PharmanexSprim Advanced Life SciencesCompletedHealth-related Quality of LifeUnited States
-
Linkoeping UniversityRecruiting
-
South Valley UniversityActive, not recruitingDeterminants of Health-related Quality of Life for Patients After Renal Lithotripsy: PNL Versus RIRSHealth Related Quality of LifeEgypt
-
Region VästmanlandUnknownHealth Related Quality of Life
Clinical Trials on Remote health coaching to improve self-care behaviors
-
Karolinska InstitutetResearch Institutes of Sweden (RISE)CompletedQuality of Life | mHealth | Mobile Applications | Lifestyle | AdultsSweden
-
Universidad de AntioquiaCompletedHypertensive Disorders of PregnancyColombia
-
University of ConnecticutMercer UniversityCompleted
-
Queen's UniversityUniversity of GondarCompletedDiabetes Mellitus, Type 2 | Type 2 DiabetesCanada
-
University of Colorado, DenverNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...CompletedDiabetes Mellitus, Type 2United States
-
University College of Northern DenmarkCompleted
-
Western University, CanadaNot yet recruiting
-
University of California, San DiegoCompleted
-
Federal University of Minas GeraisUnknownType 2 Diabetes MellitusBrazil
-
University of PittsburghAgency for Healthcare Research and Quality (AHRQ)CompletedBody Weight | Weight Loss | Motor ActivityUnited States